Cargando…

Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer

Detalles Bibliográficos
Autores principales: Liu, Huijuan, Tao, Honglian, Wang, Hongqi, Yang, Yuyan, Yang, Ru, Dai, Xintong, Ding, Xiujuan, Wu, Haidong, Chen, Shuang, Sun, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909380/
https://www.ncbi.nlm.nih.gov/pubmed/35280769
http://dx.doi.org/10.3389/fonc.2022.830506
_version_ 1784666132041433088
author Liu, Huijuan
Tao, Honglian
Wang, Hongqi
Yang, Yuyan
Yang, Ru
Dai, Xintong
Ding, Xiujuan
Wu, Haidong
Chen, Shuang
Sun, Tao
author_facet Liu, Huijuan
Tao, Honglian
Wang, Hongqi
Yang, Yuyan
Yang, Ru
Dai, Xintong
Ding, Xiujuan
Wu, Haidong
Chen, Shuang
Sun, Tao
author_sort Liu, Huijuan
collection PubMed
description
format Online
Article
Text
id pubmed-8909380
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89093802022-03-11 Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer Liu, Huijuan Tao, Honglian Wang, Hongqi Yang, Yuyan Yang, Ru Dai, Xintong Ding, Xiujuan Wu, Haidong Chen, Shuang Sun, Tao Front Oncol Oncology Frontiers Media S.A. 2022-02-24 /pmc/articles/PMC8909380/ /pubmed/35280769 http://dx.doi.org/10.3389/fonc.2022.830506 Text en Copyright © 2022 Liu, Tao, Wang, Yang, Yang, Dai, Ding, Wu, Chen and Sun https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liu, Huijuan
Tao, Honglian
Wang, Hongqi
Yang, Yuyan
Yang, Ru
Dai, Xintong
Ding, Xiujuan
Wu, Haidong
Chen, Shuang
Sun, Tao
Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer
title Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer
title_full Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer
title_fullStr Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer
title_full_unstemmed Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer
title_short Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer
title_sort corrigendum: doxycycline inhibits cancer stem cell-like properties via par1/fak/pi3k/akt pathway in pancreatic cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909380/
https://www.ncbi.nlm.nih.gov/pubmed/35280769
http://dx.doi.org/10.3389/fonc.2022.830506
work_keys_str_mv AT liuhuijuan corrigendumdoxycyclineinhibitscancerstemcelllikepropertiesviapar1fakpi3kaktpathwayinpancreaticcancer
AT taohonglian corrigendumdoxycyclineinhibitscancerstemcelllikepropertiesviapar1fakpi3kaktpathwayinpancreaticcancer
AT wanghongqi corrigendumdoxycyclineinhibitscancerstemcelllikepropertiesviapar1fakpi3kaktpathwayinpancreaticcancer
AT yangyuyan corrigendumdoxycyclineinhibitscancerstemcelllikepropertiesviapar1fakpi3kaktpathwayinpancreaticcancer
AT yangru corrigendumdoxycyclineinhibitscancerstemcelllikepropertiesviapar1fakpi3kaktpathwayinpancreaticcancer
AT daixintong corrigendumdoxycyclineinhibitscancerstemcelllikepropertiesviapar1fakpi3kaktpathwayinpancreaticcancer
AT dingxiujuan corrigendumdoxycyclineinhibitscancerstemcelllikepropertiesviapar1fakpi3kaktpathwayinpancreaticcancer
AT wuhaidong corrigendumdoxycyclineinhibitscancerstemcelllikepropertiesviapar1fakpi3kaktpathwayinpancreaticcancer
AT chenshuang corrigendumdoxycyclineinhibitscancerstemcelllikepropertiesviapar1fakpi3kaktpathwayinpancreaticcancer
AT suntao corrigendumdoxycyclineinhibitscancerstemcelllikepropertiesviapar1fakpi3kaktpathwayinpancreaticcancer